The relationship between brain tumor location and thromboembolism was studied by a retrospective review of autopsy and clinical material. Patients with suprasellar tumors had a higher incidence of thromboembolic complications than those with tumors in other locations. An associated derangement of hypothalamic function is suggested as predisposing to thromboembolism.
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brain tumor thromboembolism supraseilar tumor hypothalamus pulmonary embolism A PERSONAL observation made on the records of three patients with ectopic pinealoma in the suprasellar region revealed unexplained thromboembolic complications in each case. Two had multiple pulmonary emboli, demonstrated at postmortem examination or diagnosed clinically. The third had gross evidence of deep vein thrombophlebitis of the leg. All three patients had hypothalamic involvement by tumor as demonstrated by air study, direct operative observation, and hypothalamic malfunction including diabetes insipidus. The unusual coincidence of these thromboembolic phenomena was accentuated by the young age (early 20's) of both patients with pulmonary emboli, because pulmonary emboli are rare in young people. The suspicion was raised that hypothalamic impairment might predispose to thromboembolic disease particularly since recent experiments in the cat have shown that a hypercoagulable state may result from hypothalamic stimulation. 1 The present study was undertaken to explore the relationship between brain tumor localization and thromboembolic complications.
Method
Data were examined from autopsy and clinical records of more than 1000 patients with brain tumors seen at the Neurological Institute of New York between 1958 and 1968.
Results
The results are summarized in Table 1 . Autopsy studies showed 15 patients with suprasellar tumors. The low percentage of autopsied suprasellar tumors in this series (15 of 223) may reflect the relatively benign nature of these lesions (pituitary adenomas, craniopharyngiomas, epidermoid). These patients often live for many years and then may die in other hospitals from nontumor-related causes. Five of these (33.3%) had thromboembolic disease. There were 223 autopsied patients with brain tumors in nonsuprasellar locations. Fifteen of these (6.7%) had thromboembolic disease. These data are statistically significant at the 0.05 level.
The clinical diagnosis (nonautopsied data) of thromboembolism was made in 15 patients with brain tumors in all locations. Six of these 15 (40%) had tumors in the su- 
Discussion
Although pulmonary embolism is an important non-neurological complication of brain tumor surgery, little attention has been paid to the relationship between the two conditions. The one previous study did not discuss the relationship of tumor location to thromboembolism. 2 The present data suggest an increased tendency for patients with suprasellar and hypothalamic involvement to have thromboembolic complications. Although there is an increased risk of thromboembolism in older patients, the patients in our series with thromboembolism and suprasellar tumors were younger than those with tumors elsewhere. In neither group was there a preponderance of diagnoses of varicose veins, or cardiopulmonary disease. This further suggests that the suprasellar group was not predisposed to thromboembolism for nontumorrelated causes. Because of the diverse histology of the suprasellar tumors, it is unlikely that the type of tumor was related to thromboembolic complications.
Since the feature that these tumors had in common was their suprasellar location, an associated hypothalamic malfunction may have predisposed to thromboembolism. Possible explanations include: 1) a derangement of normal hypothalamic control of coagulation; 2) hypothalamic stimulation causing hypercoagulation; 3) hypothalamic-pituitary endocrine abnormalities causing hypercoagulation; 4) steroid therapy predisposing to thromboembolism; 5) dehydration, obesity, and/or prolonged immobilization which may be secondarily associated with hypothalamic malfunction and may themselves predispose to thromboembolism.
